Mark Lewallyn is a Partner based in New York where he focuses on strategic advice and M&A transaction execution for healthcare services & technology companies and private equity firms. He joined Centerview in 2016 as a founding member of its market-leading healthcare services and technology practice. Over the course of his career, he has advised on more than 50 transactions exceeding $250 billion in total deal value.
Representative transaction experience includes:
Payors and Value Based Care
• Express Scripts on its $67 billion sale to Cigna
• Oak Street Health on its $11 billion sale to CVS Health
• Cigna on its $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC
• Landmark Health on its $3.3 billion sale to Optum
• CareBridge on its sale to Elevance Health
• HealthSun on its $2.1 billion sale to Elevance Health
• Anthem on its $1.5 billion acquisition of America’s 1st Choice
• Humana on its $725mm acquisition of Enclara Pharmacy
• Molina Healthcare on its terminated acquisition of NextLevel Health
Pharmacy and Supply Chain
• Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline
• CPS on its sale to Optum
• Shields Health Solutions on its $2.5 billion sale to Walgreens
• Genoa Healthcare on its $2.5 billion sale to Optum
• BioPlus on its sale to Elevance Health
• CarepathRx Health System Solutions on its sale to Cigna
• Shields Health Solutions on its sale to Welsh Carson and Walgreens
• Pharmscript on its sale to Optum
• ExactCare on its $570mm acquisition of Tabula Rasa
Physician Services
• Cardinal Health on its $3.9 billion acquisition of GI Alliance
• OneOncology on its $2.1 billion sale to Cencora and TPG
• EyeCare Partners on its refinancing transactions
• InnovAge on its sale to Apax Partners
• OneOncology on its acquisition of United Urology
• Rural Medical Group on its acquisition of Steward Medical Group
• TA Associates on its acquisition of IMA Medical Group
Pharma Services
• ICON on its $12 billion acquisition of PRA Health
• PPD on its $9.1 billion recap with Hellman & Friedman and Carlyle
• Syneos on its $7.1 billion sale to Elliott, Patient Square and Veritas
• INC Research on its $7 billion merger of equals with inVentiv Health
• inVentiv Health on its $3.7 billion sale to Advent
• Kohlberg on its acquisition of Worldwide Clinical Trials
• PharmaCord on its sale to Permira
• UBC, a subsidiary of Express Scripts, on its sale to Avista Capital
Healthcare Technology
• MultiPlan on its $11 billion combination with Churchill Capital
• MedRisk on its sale to CVC Capital
• TransUnion RCM, a subsidiary of TransUnion, on its $1.7 billion sale to nThrive
• Kohlberg on its acquisition of Trinity Life Sciences
• Fresenius Medical in its participation in Humacyte’s $1.1 billion merger with Alpha Health
• Wellframe on its sale to Healthedge Software
• EQT on its acquisition of Certara
Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.
He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.